argipressin, val(4)- has been researched along with 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin in 1 studies
| Studies (argipressin, val(4)-) | Trials (argipressin, val(4)-) | Recent Studies (post-2010) (argipressin, val(4)-) | Studies (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Trials (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) | Recent Studies (post-2010) (1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 35 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liard, JF | 1 |
1 other study(ies) available for argipressin, val(4)- and 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin
| Article | Year |
|---|---|
Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Bone and Bones; Cardiac Output; Cardiovascular Physiological Phenomena; Cardiovascular System; Dehydration; Dogs; Hemodynamics; Kidney; Liver; Male; Vascular Resistance; Vasoconstriction | 1986 |